Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...
New Access, Safety Standards, and Field Expertise Explained Coalinga, United States – December 1, 2025 / Conservative Game ...
MCLEAN, VA / ACCESS Newswire / December 1, 2025 / Gladstone Alternative Income Fund (“Gladstone Alternative” or the “Fund”) announced today that its board of trustees declared monthly cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results